Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer

doi:10.5492/wjccm.v2.i4.48

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7305)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

429

HTML

3761

Figures (1-5)

537

Tables (1-2)

410

Sum=5137

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1292

Download

876

Sum=2168

Nov 4, 2013 (publication date) through Jan 7, 2025

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Critical Care Medicine

ISSN

2220-3141

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Crit Care Med. Nov 4, 2013; 2(4): 48-55
Published online Nov 4, 2013. doi: 10.5492/wjccm.v2.i4.48

Full Size Figure Download Figure

Figure 1 Peritoneal dissemination model. A: Bloody ascites was recognized in the peritoneal cavity of the peritoneal dissemination model, using the MKN-45P cell line; B: Numerous tumor nodules (arrowheads) were recognized on the mesentery.

Citation: Aoyagi K, Kouhuji K, Miyagi M, Kizaki J, Isobe T, Hashimoto K, Shirouzu K. Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer. World J Crit Care Med 2013; 2(4): 48-55
URL: https://www.wjgnet.com/2220-3141/full/v2/i4/48.htm
DOI: https://dx.doi.org/10.5492/wjccm.v2.i4.48